| Louis W Raben Iii, CRNA | |
|
710 Center St, Columbus, GA 31901-1527 | |
| (706) 571-1374 | |
| (706) 660-2686 |
| Full Name | Louis W Raben Iii |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 32 Years |
| Location | 710 Center St, Columbus, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164416293 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | RN075188 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Piedmont Columbus Regional Midtown | Columbus, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Sentry Anesthesia Management, Llc | 9436372323 | 209 |
News Archive
Micro Imaging Technology, Inc. today announced that it has changed is company name to Micro Identification Technologies to better reflect the extensive capabilities of its ID technology software.
Elan Corporation, plc (NYSE: ELN) announced today the first patient dosing in a Phase 2a study of ELND005 in Down syndrome. Study ELND005-DS201 will evaluate the safety and pharmacokinetics of 2 doses of ELND005 and placebo in young adults with Down syndrome without dementia, and will also include select cognitive and behavioural measures.
Despite over a third (40%) of workers globally revealing they are worried about their long-term health, 40% admit they haven't had a health check in the last year and a significant number have no idea about simple measures of health, such as cholesterol levels, according to new research published today.
Deadly familial stomach and lobular breast cancers could be successfully treated at their earliest stages, or even prevented, by existing drugs that have been newly identified by cancer genetics researchers at New Zealand's University of Otago.
Whether a wound-such as a diabetic foot ulcer-heals or progresses to a worse outcome, including infection or even amputation, may depend on the microbiome within that wound.
› Verified 5 days ago
| Entity Name | Amsol Anesthetists Of Georgia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649224775 PECOS PAC ID: 5193780955 Enrollment ID: O20041122000580 |
News Archive
Micro Imaging Technology, Inc. today announced that it has changed is company name to Micro Identification Technologies to better reflect the extensive capabilities of its ID technology software.
Elan Corporation, plc (NYSE: ELN) announced today the first patient dosing in a Phase 2a study of ELND005 in Down syndrome. Study ELND005-DS201 will evaluate the safety and pharmacokinetics of 2 doses of ELND005 and placebo in young adults with Down syndrome without dementia, and will also include select cognitive and behavioural measures.
Despite over a third (40%) of workers globally revealing they are worried about their long-term health, 40% admit they haven't had a health check in the last year and a significant number have no idea about simple measures of health, such as cholesterol levels, according to new research published today.
Deadly familial stomach and lobular breast cancers could be successfully treated at their earliest stages, or even prevented, by existing drugs that have been newly identified by cancer genetics researchers at New Zealand's University of Otago.
Whether a wound-such as a diabetic foot ulcer-heals or progresses to a worse outcome, including infection or even amputation, may depend on the microbiome within that wound.
› Verified 5 days ago
| Entity Name | Sentry Anesthesia Management, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134544794 PECOS PAC ID: 9436372323 Enrollment ID: O20140521002571 |
News Archive
Micro Imaging Technology, Inc. today announced that it has changed is company name to Micro Identification Technologies to better reflect the extensive capabilities of its ID technology software.
Elan Corporation, plc (NYSE: ELN) announced today the first patient dosing in a Phase 2a study of ELND005 in Down syndrome. Study ELND005-DS201 will evaluate the safety and pharmacokinetics of 2 doses of ELND005 and placebo in young adults with Down syndrome without dementia, and will also include select cognitive and behavioural measures.
Despite over a third (40%) of workers globally revealing they are worried about their long-term health, 40% admit they haven't had a health check in the last year and a significant number have no idea about simple measures of health, such as cholesterol levels, according to new research published today.
Deadly familial stomach and lobular breast cancers could be successfully treated at their earliest stages, or even prevented, by existing drugs that have been newly identified by cancer genetics researchers at New Zealand's University of Otago.
Whether a wound-such as a diabetic foot ulcer-heals or progresses to a worse outcome, including infection or even amputation, may depend on the microbiome within that wound.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Louis W Raben Iii, CRNA Po Box 1380, Columbus, GA 31902-1307 Ph: (706) 571-1374 | Louis W Raben Iii, CRNA 710 Center St, Columbus, GA 31901-1527 Ph: (706) 571-1374 |
News Archive
Micro Imaging Technology, Inc. today announced that it has changed is company name to Micro Identification Technologies to better reflect the extensive capabilities of its ID technology software.
Elan Corporation, plc (NYSE: ELN) announced today the first patient dosing in a Phase 2a study of ELND005 in Down syndrome. Study ELND005-DS201 will evaluate the safety and pharmacokinetics of 2 doses of ELND005 and placebo in young adults with Down syndrome without dementia, and will also include select cognitive and behavioural measures.
Despite over a third (40%) of workers globally revealing they are worried about their long-term health, 40% admit they haven't had a health check in the last year and a significant number have no idea about simple measures of health, such as cholesterol levels, according to new research published today.
Deadly familial stomach and lobular breast cancers could be successfully treated at their earliest stages, or even prevented, by existing drugs that have been newly identified by cancer genetics researchers at New Zealand's University of Otago.
Whether a wound-such as a diabetic foot ulcer-heals or progresses to a worse outcome, including infection or even amputation, may depend on the microbiome within that wound.
› Verified 5 days ago
Samuel Solomon Marks, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 710 Center St, Columbus, GA 31901 Phone: 706-571-1000 | |
Terri Christine Buckner, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 616 19th St, Columbus, GA 31901 Phone: 706-494-4262 | |
Gregory Whitfield, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2122 Manchester Expy, Columbus, GA 31904 Phone: 705-596-4000 | |
Greg Walsh, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 2122 Manchester Expy, Columbus, GA 31904 Phone: 706-596-4000 | |
Rachel M Sneed, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2122 Manchester Expy, Columbus, GA 31904 Phone: 706-596-4000 | |
Brandon Fletcher, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 6600 Van Aalst Blvd, Martin Army Community Hospital, Columbus, GA 31905 Phone: 706-544-2563 | |
Sharon S Johnson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 710 Center St, Columbus, GA 31901 Phone: 706-571-1374 Fax: 706-660-2686 |